Guangxi Wuzhou Zhongheng Group Co., Ltd (SHA:600252)
2.590
+0.020 (0.78%)
Mar 10, 2026, 3:00 PM CST
SHA:600252 Revenue
Guangxi Wuzhou Zhongheng Group had revenue of 497.08M CNY in the quarter ending September 30, 2025, a decrease of -3.65%. This brings the company's revenue in the last twelve months to 2.29B, down -19.79% year-over-year. In the year 2024, Guangxi Wuzhou Zhongheng Group had annual revenue of 2.27B, down -26.67%.
Revenue (ttm)
2.29B
Revenue Growth
-19.79%
P/S Ratio
3.57
Revenue / Employee
771.49K
Employees
2,971
Market Cap
8.18B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2.27B | -825.72M | -26.67% |
| Dec 31, 2023 | 3.10B | 382.77M | 14.10% |
| Dec 31, 2022 | 2.71B | -448.07M | -14.17% |
| Dec 31, 2021 | 3.16B | -514.55M | -14.00% |
| Dec 31, 2020 | 3.68B | -137.66M | -3.61% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Renhe Pharmacy Co.,Ltd | 3.76B |
| China Animal Husbandry Industry | 6.28B |
| Guilin Sanjin Pharmaceutical | 2.08B |
| Zhejiang Tianyu Pharmaceutical | 2.99B |
| Hubei Hongyuan Pharmaceutical Technology | 1.77B |
| Hunan Er-Kang Pharmaceutical | 1.29B |
| Sunflower Pharmaceutical Group Co.,Ltd | 2.09B |
| Jiangsu Kanion Pharmaceutical | 3.13B |